🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has removed violative content and banned related hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, glowing reviews and detailed guides for preparing or administering at home.

Within moments of joining one group, a vendor shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Product Details and Costs

Inside these communities, messages show dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly serious medical dangers”.